All chronical situations: 21 trials - Tuttle - WHI low fat - Black - Singh - STARS (St Thomas, diet) - Ornish - Goteborg - Göteborg (Wilhelmsen) - WHO Collaborative - Finnish Mental Hospital (Miettinen) - MRFIT - Hjermann - Kallio - Minnesota coronary survey (Frantz) - Los Angeles VA (Dayton) - Veterans Ad. (Dayton) - MRC Soya - Oslo Diet Heart Study (Leren) - Woodhill - MRC low fat - Rose
All type of patients: 21 trials - Tuttle - WHI low fat - Black - Singh - STARS (St Thomas, diet) - Ornish - Goteborg - Göteborg (Wilhelmsen) - WHO Collaborative - Finnish Mental Hospital (Miettinen) - MRFIT - Hjermann - Kallio - Minnesota coronary survey (Frantz) - Los Angeles VA (Dayton) - Veterans Ad. (Dayton) - MRC Soya - Oslo Diet Heart Study (Leren) - Woodhill - MRC low fat - Rose
Pateints at low risk: 1 trials - Mate-Jimenez
Patients at high risk: 2 trials - Burr (DART 2) - Burr (DART)
Patients with LDL elevation and without CHD: 6 trials - Goteborg - WHO Collaborative - Finnish Mental Hospital (Miettinen) - MRFIT - Hjermann - Veterans Ad. (Dayton)
Patients with prior MI or with CHD: 7 trials - Tuttle - Singh - STARS (St Thomas, diet) - Ornish - Kallio - Los Angeles VA (Dayton) - Rose
All type of patients : 1 trials - Liao
People with impaired glucose tolerance: 1 trials - Liao